1.北京中医药大学东直门医院脑病科,北京100700
2.北京中医药大学中医脑病研究院,北京100700
3.北京大学人民医院神经内科,北京100044
刘深,男,35岁,博士,主治医师。研究方向:脑血管病的中医药防治研究。
高颖,E-mail:gaoying973@126.com
扫 描 看 全 文
刘深,张兆旭,高颖.补气摄血法防治脑梗死溶栓后出血转化探析[J].北京中医药,2022,41(7):725-727.
LIU Shen,ZHANG Zhao-xu,GAO Ying.Study on traditional Chinese medicine tonifying Qi to control blood flow therapy for preventing and treating hemorrhagic transformation after thrombolysis in ischemic stroke[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(07):725-727.
刘深,张兆旭,高颖.补气摄血法防治脑梗死溶栓后出血转化探析[J].北京中医药,2022,41(7):725-727. DOI: 10.16025/j.1674-1307.2022.07.005.
LIU Shen,ZHANG Zhao-xu,GAO Ying.Study on traditional Chinese medicine tonifying Qi to control blood flow therapy for preventing and treating hemorrhagic transformation after thrombolysis in ischemic stroke[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(07):725-727. DOI: 10.16025/j.1674-1307.2022.07.005.
出血转化是脑梗死溶栓后的常见并发症之一,症状性出血转化已被明确证实是与脑梗死不良预后密切相关的重要因素,而目前临床尚无明确有效的防治措施。本文从中医理论探讨脑梗死溶栓后出血转化的病机,提出“破瘀耗气、气虚不摄”是其发生的核心病机,离经之血即瘀血,乃脑梗死溶栓后气虚不摄的结果。基于此病机,确立了补气摄血是脑梗死溶栓后出血转化的防治原则,并在该治法的基础上针对离经之瘀血配合应用益气化瘀法,为中医药防治该病变提供新策略。
脑梗死溶栓后出血转化补气摄血法中医病机防治策略
YAGHI S,WILLEY JZ,CUCCHIARA B,et al.Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke:a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2017,48(12):e343-e361.
WHITELEY WN,THOMPSON D,MURRAY G,et al.Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome:an analysis of the third international stroke trial[J].Stroke,2014,45(4):1000-1006.
中华医学会神经病学分会脑血管病学组.中国急性脑梗死后出血转化诊治共识2019[J].中华神经科杂志,2019,52(4): 252-265.
ZHU T,WANG L,WANG LP,et al.Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke:Applications for natural compounds from medicinal herbs[J].Biomed Pharmacother,2022,148: 112719.
HONG JM,KIM DS,KIM M.Hemorrhagic transformation after ischemic stroke:mechanisms and management[J].Front Neurol,2021,12:703258.
SPRONK E,SYKES G,FALCIONE S,et al.Hemorrhagic transformation in ischemic stroke and the role of inflammation[J].Front Neurol,2021,12:661955.
SHI KB,ZOU M,JIA DM,et al.tPA Mobilizes immune cells that exacerbate hemorrhagic transformation in stroke[J].Circ Res,2021,128(1):62-75.
KAUR J,ZHAO Z,KLEIN GM,et al.The neurotoxicity of tissue plasminogen activator[J].J Cereb Blood Flow Metab,2004,24(9):945-963.
CUADRADO E,ORTEGA L,HERNANDEZ-GUILLAMON M,et al.Tissue plasminogen activator(t-PA)promotes neutrophil degranulation and MMP-9 release[J].J Leukoc Biol,2008,84(1):207-214.
SU EJ,FREDRIKSSON L,GEYER M,et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke[J].Nat Med,2008,14(7):731-737.
LAKHAN SE,KIRCHGESSNER A,TEPPER D,et al.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke[J].Front Neurol,2013,4:32.
张红星,柯英利,武涛,等.活血化瘀法结合常规西医治疗高血压性脑出血急性期临床疗效观察[J].四川中医,2017,35(3):113-118.
黄燕,贾翔,孙景波.急性缺血性卒中溶栓后出血转化的中医药干预思路[J].时珍国医国药,2011,22(7):1749-1750.
锁苗.血糖对急性脑梗死rt-PA静脉溶栓后出血转化的影响及中医证候演变研究[D].广州:广州中医药大学,2021.
殷昆昆,勾向博,万梅绪,等.生脉方治疗心力衰竭的药理作用研究进展[J].药物评价研究,2020,43(8):1501-1505.
PAN XW,WANG MJ,GONG SS,et al.YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-kappaB signaling pathways[J].J Ethnopharmacol,2020,262:113161.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构